KLSE: PHARMA (7081)       PHARMANIAGA BHD MAIN : Trading&Services
Last Price Today's Change   Day's Range   Trading Volume
4.08   -0.01 (0.24%)  4.08 - 4.09  20,900
Analyze this stock with MQ Trader system


Market Cap: 1,058 Million
NOSH: 259 Million
Avg Volume (4 weeks):213,627
4 Weeks Range:3.94 - 4.65
4 Weeks Price Volatility (%):
52 Weeks Range:3.65 - 5.28
52 Weeks Price Volatility (%):
Average Price Target: 3.96
Price Target Upside/Downside: -0.12

Financial Highlight

Latest Quarter | Ann. Date 30-Sep-2017[#3]  |  15-Nov-2017
Next QR | Est. Ann. Date: 31-Dec-2017  |  21-Feb-2018
T4Q P/E | EY: 33.94  |  2.95%
T4Q DY | Payout %: 3.92%  |  133.03%
T4Q NAPS | P/NAPS: 2.05  |  1.99
T4Q NP Margin | ROE: 1.40%  |  5.86%


Date Subject
06-Dec-2017 Mplus Market Pulse - 6 Dec 2017
06-Dec-2017 PublicInvest Research Headlines - 6 Dec 2017
16-Nov-2017 Mplus Market Pulse - 16 Nov 2017
16-Nov-2017 Pharmaniaga Bhd - 9M17 Below Expectations
16-Nov-2017 Pharmaniaga - Hit By Closure of Production Line
08-Sep-2017 Company Update - Pharmaniaga-Transformation in the Making
17-Aug-2017 获利逊色.营运增高.发马须快速扩大市场
17-Aug-2017 Pharmaniaga - Temporary Drag On Earnings From Production Line Closure
17-Aug-2017 Pharmaniaga - Impacted By Closure of Production Lines
17-Aug-2017 PublicInvest Research Headlines - 17 Aug 2017
17-Aug-2017 Pharmaniaga Bhd - 1H17 Within Expectations
17-Aug-2017 Mplus Market Pulse - 17 Aug 2017
24-Jul-2017 Pharmaniaga
18-May-2017 私人领域及印尼业务向好.发马全年业绩有望达标
17-May-2017 Pharmaniaga Bhd - 1Q17 Broadly Inline With Expectations
17-May-2017 Pharmaniaga - 1Q17 In The Black
17-May-2017 Pharmaniaga - Earnings Boosted By Higher Revenue From L&D
17-May-2017 Mplus Market Pulse - 17 May 2017
17-Apr-2017 最糟时期已过.发马盈利回到正轨
13-Apr-2017 医药预算大砍60亿.发马短期难有起色

Business Background

Pharmaniaga Berhad is an investment holding company. The Company operates in four segments: pharmaceutical manufacturing, which is engaged in the manufacturing of pharmaceutical products; Pharmaceutical trading, marketing and distribution, which is engaged in the purchasing, marketing, storage and distribution of and distribution pharmaceutical and medical products; medical products and services, which is engaged in the supply and installation of medical and hospital equipment, and Other operations, which is engaged in the investment holding. Its subsidiaries include Pharmaniaga Manufacturing Berhad, Pharmaniaga LifeScience Sdn. Bhd., Pharmaniaga Logistics Sdn. Bhd, Pharmaniaga Marketing Sdn. Bhd, Pharmaniaga Research Centre Sdn. Bhd., Insurgress Sdn. Bhd., Safire Pharmaceuticals (M) Sdn. Bhd. and Pharmaniaga International Corporation Sdn. Bhd.
Trade this stock with T+7 trading account. Find out more.

  2 people like this.
Chinkang B19. Prospects

While external economic pressures will continue to persist in 2016, there are bright prospects for the pharmaceutical sector that the Group is well positioned to tap into. A clear reflection of this are the initiative outlined in the National Budget 2016, which include a higher allocation for vaccines and medicines, an increase in the number of GST zero-rated medicines, as welll as more clinics and hospitals to be built nationwide.

In addition, the group aims to expand it's presence in the European Union via it's product portfolio, which is undergoing the necessary review and registration process. It also intends to mould it's Indonesian manufacturing subsidiary into and important manufacturing and export hub for the ASEAN region.

The Group is focused on leveraging on these opportunities by enhancing and diversifying its products and services to meet the growing needs of the healthcare industry, both in Malaysia and International markets.
03/03/2016 15:03
leecuteguy external economic pressures will only make more people to do panic selling.........people will not think much of fundamental for this counter....no doubt, price will drop if panic selling happen
03/03/2016 19:38
ruby828 think this counter is ok.....but i dunno whether now is a good time to enter?
04/03/2016 10:13
ruby828 Chinkang, thanxs for the info and advice.
04/03/2016 10:14
ruby828 Beautiful....5.70
04/03/2016 13:05
Chinkang @ruby that's just my opinion. Based on the historical charts, share price will dropped after dividend entitlement date then it will increase back, however pharma is walking down trend recently.
For short term, shouldn't consider this company, for long term, yes.
04/03/2016 14:51
ruby828 noted....
04/03/2016 16:26
Asia88 Let throw Tan Sri out of office. He is Chairman of 1MDB( questionable entity). Share price drop so much.
04/03/2016 18:28
ruby828 hehehhe....
07/03/2016 08:12
ruby828 if break 5.70.....it might go down to 5.40......:)
07/03/2016 14:47
ruby828 beautiful.....
08/03/2016 09:37
SingInvestor ruby your dream price coming soon.....5.40....Good.!!!!
09/03/2016 22:34
ruby828 iya...y rebound so soon...
10/03/2016 16:51
CUTLOST Hope will rebound soon to 5.70
18/03/2016 11:55
billionchew sure rebound, keep hold & keep confident, dun worry!
18/03/2016 22:54
tuapuikia I made many from this counter. but not sure it is good to in now
19/03/2016 18:49
shortinvestor77 Yes, of course. The management will solve the operating cost high problem. See the revenue keeps increasing. Likewise for dividends. One time profit down does mean it will always down. Refer to Media as an example.I got only 2000 units. Thinking of buy more.
19/03/2016 22:06
shortinvestor77 Does not mean. Correction
19/03/2016 22:06
shortinvestor77 Increasing profit by:
23/03/2016 21:40
Chinkang Good day!
07/04/2016 17:12
Bob Barley Tppa will affect this market?
07/04/2016 18:20
SingInvestor Wow sudden rise......,,up?
07/04/2016 22:53
Chinkang 13mil shares trade at 6.26
07/04/2016 23:00
shortinvestor77 So, it is worth at least RM6.26.
08/04/2016 23:33
shortinvestor77 Buying
12/04/2016 21:44
891088 Buy now b4 too late
16/04/2016 23:41
shortinvestor77 Good buy now.
01/05/2016 18:36
shortinvestor77 Really a good buy.
08/05/2016 17:19
shortinvestor77 Revenue increases but net profit decreases. Pro and con. 5 cents div is good.
21/08/2016 21:31
NavinShah Kayu directors jadi kaya lah. Sumua masuk koche lah.
21/02/2017 13:42
Lincorn Matthieu Seven profit drop -ve
21/02/2017 13:42
ruskymee It hits the 52 weeks lowest price. Should consider to buy some for long term investment.
22/02/2017 10:17
supergreat should sell phamaniaga and switch to kotra pharma or ccmbio
22/02/2017 11:50
jibbie everyday keep dropping.. when will it hit rock bottom?
06/04/2017 15:54
jibbie should be rock bottom now and safe to enter.
07/04/2017 07:57
jibbie oversold
17/04/2017 08:24
meistsk3134 got related to politic? funding politic?
14/08/2017 23:05
limkokthye gov hospital no $$$ to good medicine from phamaniaga
28/09/2017 10:35
Investeye At per yesterday closing price, it is worth to look for opportunity to accumulate ...
09/11/2017 09:23
Bryanlau Bad QR no surprise, share price already drop ahead.
Good thing is dividend better than last QR.
Good buy now?
16/11/2017 06:51
Bryanlau Bad QR no surprise, share price already drop ahead.
Good thing is dividend better than last QR.
Good buy now?
16/11/2017 06:51
KC53 People now struggling with butter n bread. G't no better, medicine now generic to cut cost. Ori have to buy outside, pay yourself.
16/11/2017 22:35
lipas bad cost management, shall stay away from this counter
30/11/2017 23:30
limkokthye run la, all time low
06/12/2017 00:05
lipas please run before too late
07/12/2017 22:00
Amit Khindriya today drop so much....why?
26/12/2017 13:46
Mohd Fahmi Bin Jaes Now up so much
28/12/2017 17:22
DBEX ups
28/12/2017 17:23
Greenspan Pharma price like riding roller coster...up n down ...up n down
29/12/2017 10:52
hipster this LEMBAGA TABUNG ANGKATAN TENTERA is pushing up the price, dunno for what?
29/12/2017 10:59


525  337  527  471 

Top 10 Active Counters
 SUMATEC 0.105+0.01 
 UMWOG 0.365+0.02 
 SAPNRG 0.84+0.08 
 HUAAN 0.55+0.08 
 APFT 0.015-0.01 
 HENGYUAN-CO 0.275+0.125 
 PUC 0.29+0.005 
 HIBISCS 1.06+0.03 
 NETX 0.0450.00 
 UMWOG-WA 0.18+0.01 
Partners & Brokers